Literature DB >> 32485111

Pathological Comparisons of Paraseptal and Centrilobular Emphysema in COPD.

Naoya Tanabe1,2, Dragoş M Vasilescu1, Cameron J Hague3, Kohei Ikezoe1, Darra T Murphy3, Miranda Kirby4,1, Christopher S Stevenson5, Stijn E Verleden6, Bart M Vanaudenaerde6, Ghislaine Gayan-Ramirez6, Wim Janssens6, Harvey O Coxson1, Peter D Paré1, James C Hogg1.   

Abstract

RATIONALE: While centrilobular (CLE) and paraseptal (PSE) emphysema are commonly identified on multi-detector computed tomography (MDCT), little is known about the pathology associated with PSE compared to CLE.
OBJECTIVE: To assess the pathological differences between PSE and CLE in chronic obstructive pulmonary disease (COPD).
METHODS: Air-inflated frozen lung specimens (n=6) obtained from patients with severe COPD treated by lung transplantation were scanned with MDCT. Frozen tissue cores were taken from central (n=8) and peripheral (n=8) regions of each lung, scanned with microCT, and processed for histology. The core locations were registered to the MDCT and a percentage of PSE or CLE was assigned by radiologists to each of the regions. MicroCT scans were used to measure number and structural change of terminal bronchioles. Further, microCT based volume fractions of centrilobular (CLE%) and paraseptal (PSE%) emphysema allowed classifying cores into mild emphysema, CLE-dominant, and PSE-dominant.
MEASUREMENTS AND MAIN RESULTS: PSE% measured on MDCT and microCT were positively associated (p=0.015). Number of terminal bronchioles per ml of lung and cross-sectional lumen area were significantly lower while wall area percent was significantly higher in CLE-dominant compared to mild emphysema and PSE-dominant regions (all p<0.05), whereas no difference was found between PSE-dominant and mild emphysema samples (all p>0.5). Immunohistochemistry showed significantly higher infiltration of neutrophils (p=0.002), but not of macrophages, CD4, CD8, or B cells, in PSE compared to CLE regions.
CONCLUSIONS: The terminal bronchioles are relatively preserved while neutrophilic inflammation is increased in PSE-dominant regions compared to CLE-dominant regions in patents with COPD.

Entities:  

Keywords:  COPD; Emphysema; MicroCT; Small airway disease

Year:  2020        PMID: 32485111     DOI: 10.1164/rccm.201912-2327OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  CT-defined visual emphysema in smokers with normal spirometry: association with prolonged air leak and other respiratory complications after lobectomy for lung cancer.

Authors:  Taeyoung Yun; Hyewon Choi; Hyungjin Kim; Kwon Joong Na; Samina Park; In Kyu Park; Chang Hyun Kang; Jin Mo Goo; Young Tae Kim
Journal:  Eur Radiol       Date:  2022-01-29       Impact factor: 5.315

2.  Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease.

Authors:  Auyon J Ghosh; Brian D Hobbs; Matthew Moll; Aabida Saferali; Adel Boueiz; Jeong H Yun; Frank Sciurba; Lucas Barwick; Andrew H Limper; Kevin Flaherty; Gerard Criner; Kevin K Brown; Robert Wise; Fernando J Martinez; David Lomas; Peter J Castaldi; Vincent J Carey; Dawn L DeMeo; Michael H Cho; Edwin K Silverman; Craig P Hersh
Journal:  Am J Respir Crit Care Med       Date:  2022-02-01       Impact factor: 21.405

3.  The prevalence and physiological impacts of centrilobular and paraseptal emphysema on computed tomography in smokers with preserved ratio impaired spirometry.

Authors:  Yusuke Shiraishi; Takafumi Shimada; Naoya Tanabe; Kunihiko Terada; Ryo Sakamoto; Tomoki Maetani; Hiroshi Shima; Fumi Mochizuki; Tsuyoshi Oguma; Kaoruko Shimizu; Susumu Sato; Shigeo Muro; Nobuyuki Hizawa; Motonari Fukui; Hiroaki Iijima; Izuru Masuda; Toyohiro Hirai
Journal:  ERJ Open Res       Date:  2022-06-27

4.  Update in Chronic Obstructive Pulmonary Disease 2020.

Authors:  Andy I Ritchie; Jonathon R Baker; Trisha M Parekh; James P Allinson; Surya P Bhatt; Louise E Donnelly; Gavin C Donaldson
Journal:  Am J Respir Crit Care Med       Date:  2021-07-01       Impact factor: 21.405

5.  Paraseptal Emphysema: From the Periphery of the Lobule to the Center of the Stage.

Authors:  Alejandro A Diaz
Journal:  Am J Respir Crit Care Med       Date:  2020-09-15       Impact factor: 21.405

6.  Computed tomography-based visual assessment of chronic obstructive pulmonary disease: comparison with pulmonary function test and quantitative computed tomography.

Authors:  Han Sol Kang; So Hyeon Bak; Ha Yeun Oh; Myoung-Nam Lim; Yoon Ki Cha; Hyun Jung Yoon; Woo Jin Kim
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

7.  The presence of emphysema on chest imaging and mid-life cognition.

Authors:  Benjamin E Henkle; Laura A Colangelo; Mark T Dransfield; Lifang Hou; David R Jacobs; Brian T Joyce; Carrie L Pistenmaa; Rachel K Putman; Steve Sidney; Bharat Thyagarajan; George R Washko; Kristine Yaffe; Ravi Kalhan; Ken M Kunisaki
Journal:  ERJ Open Res       Date:  2021-03-15

8.  Adenocarcinoma in situ and minimally invasive adenocarcinoma in lungs of smokers: image feature differences from those in lungs of non-smokers.

Authors:  Haruto Sugawara; Hirokazu Watanabe; Akira Kunimatsu; Osamu Abe; Shun-Ichi Watanabe; Yasushi Yatabe; Masahiko Kusumoto
Journal:  BMC Med Imaging       Date:  2021-11-19       Impact factor: 1.930

9.  Lung tissue shows divergent gene expression between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

Authors:  Auyon J Ghosh; Brian D Hobbs; Jeong H Yun; Aabida Saferali; Matthew Moll; Zhonghui Xu; Robert P Chase; Jarrett Morrow; John Ziniti; Frank Sciurba; Lucas Barwick; Andrew H Limper; Kevin Flaherty; Gerard Criner; Kevin K Brown; Robert Wise; Fernando J Martinez; Daniel McGoldrick; Michael H Cho; Dawn L DeMeo; Edwin K Silverman; Peter J Castaldi; Craig P Hersh
Journal:  Respir Res       Date:  2022-04-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.